Literature DB >> 21734567

Innate immunity in acute HIV-1 infection.

Persephone Borrow1.   

Abstract

PURPOSE OF REVIEW: Acute HIV-1 infection (AHI) is composed of the eclipse phase, during which the transmitted virus struggles to avoid eradication and achieve amplification/spread; the expansion phase when virus disseminates and undergoes exponential replication associated with extensive CD4⁺ T-cell destruction; and the containment phase when set-point levels of viremia and immune activation are established. The importance of interactions between HIV-1 and innate responses in determining events throughout AHI is increasingly recognized, and is reviewed here. RECENT
FINDINGS: During the eclipse phase, HIV-1 subverts dendritic cell functions to promote its replication at mucosal sites and employs multiple strategies to minimize control by type 1 interferons. Systemic virus dissemination is associated with widespread activation of innate responses which fuels HIV-1 replication. To minimize the protective effects of innate responses, HIV-1 resists control by natural killer cells and may impair innate regulation of adaptive responses. Innate responses remain chronically activated after HIV-1 containment which is thought to drive HIV-1 pathogenesis.
SUMMARY: Innate responses are pivotal determinants of events at all stages of AHI. Increased understanding of mechanisms involved in innate control of HIV-1 and pathways regulating innate activation during HIV-1 infection could facilitate development of novel approaches to combating this infection.

Entities:  

Mesh:

Year:  2011        PMID: 21734567      PMCID: PMC3266478          DOI: 10.1097/COH.0b013e3283495996

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  100 in total

1.  Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection.

Authors:  Qingsheng Li; Anthony J Smith; Timothy W Schacker; John V Carlis; Lijie Duan; Cavan S Reilly; Ashley T Haase
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

2.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

3.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

4.  HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.

Authors:  Galit Alter; Suzannah Rihn; Katharine Walter; Anne Nolting; Maureen Martin; Eric S Rosenberg; Jeffrey S Miller; Mary Carrington; Marcus Altfeld
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

5.  Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells.

Authors:  Yufei Wang; Lesley A Bergmeier; Richard Stebbings; Thomas Seidl; Trevor Whittall; Mahavir Singh; Neil Berry; Neil Almond; Thomas Lehner
Journal:  Vaccine       Date:  2008-12-11       Impact factor: 3.641

6.  Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.

Authors:  Emma L Turnbull; MaiLee Wong; Shuyi Wang; Xiping Wei; Nicola A Jones; Karen E Conrod; Diana Aldam; Jo Turner; Pierre Pellegrino; Brandon F Keele; Ian Williams; George M Shaw; Persephone Borrow
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

7.  HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.

Authors:  Hugues Fausther-Bovendo; Nathalie Sol-Foulon; Daniel Candotti; Henri Agut; Olivier Schwartz; Patrice Debré; Vincent Vieillard
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

8.  Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization.

Authors:  Sharon Lederer; David Favre; Kathie-Anne Walters; Sean Proll; Bittoo Kanwar; Zeljka Kasakow; Carole R Baskin; Robert Palermo; Joseph M McCune; Michael G Katze
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

9.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

Authors:  Nilu Goonetilleke; Michael K P Liu; Jesus F Salazar-Gonzalez; Guido Ferrari; Elena Giorgi; Vitaly V Ganusov; Brandon F Keele; Gerald H Learn; Emma L Turnbull; Maria G Salazar; Kent J Weinhold; Stephen Moore; Norman Letvin; Barton F Haynes; Myron S Cohen; Peter Hraber; Tanmoy Bhattacharya; Persephone Borrow; Alan S Perelson; Beatrice H Hahn; George M Shaw; Bette T Korber; Andrew J McMichael
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

10.  Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response.

Authors:  Agnieszka Kielczewska; Michal Pyzik; Tianhe Sun; Astrid Krmpotic; Melissa B Lodoen; Michael W Munks; Marina Babic; Ann B Hill; Ulrich H Koszinowski; Stipan Jonjic; Lewis L Lanier; Silvia M Vidal
Journal:  J Exp Med       Date:  2009-03-02       Impact factor: 14.307

View more
  29 in total

1.  Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.

Authors:  Namal P M Liyanage; Shari N Gordon; Melvin N Doster; Poonam Pegu; Monica Vaccari; Nebiyu Shukur; Luca Schifanella; Cynthia A Pise-Masison; Danuta Lipinska; Kamil Grubczak; Marcin Moniuszko; Genoveffa Franchini
Journal:  Virology       Date:  2014-01-21       Impact factor: 3.616

2.  Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Thorsten Demberg; Ranajit Pal; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

3.  Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques.

Authors:  Diego A Vargas-Inchaustegui; Sabrina Helmold Hait; Hye Kyung Chung; Jigna Narola; Tanya Hoang; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

4.  Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation.

Authors:  Christopher W Peterson; Kevin G Haworth; Patricia Polacino; Meei-Li Huang; Craig Sykes; Willimark M Obenza; Andrea C Repetto; Angela Kashuba; Roger Bumgarner; Stephen C DeRosa; Ann E Woolfrey; Keith R Jerome; James I Mullins; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

Review 5.  Dynamics of innate immunity are key to chronic immune activation in AIDS.

Authors:  Arndt Benecke; Michael Gale; Michael G Katze
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

Review 6.  How the evolving epidemics of opioid misuse and HIV infection may be changing the risk of oral sexually transmitted infection risk through microbiome modulation.

Authors:  Wiley D Jenkins; Lauren B Beach; Christofer Rodriguez; Lesli Choat
Journal:  Crit Rev Microbiol       Date:  2020-01-30       Impact factor: 7.624

7.  Deep transcriptional sequencing of mucosal challenge compartment from rhesus macaques acutely infected with simian immunodeficiency virus implicates loss of cell adhesion preceding immune activation.

Authors:  Fredrik Barrenas; Robert E Palermo; Brian Agricola; Michael B Agy; Lauri Aicher; Victoria Carter; Leon Flanary; Richard R Green; Randy McLain; Qingsheng Li; Wuxun Lu; Robert Murnane; Xinxia Peng; Matthew J Thomas; Jeffrey M Weiss; David M Anderson; Michael G Katze
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

Review 8.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 9.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 10.  Dendritic cell dysregulation during HIV-1 infection.

Authors:  Elizabeth Miller; Nina Bhardwaj
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.